Adrenoceptor of the alpha 2-subtype mediating inhibition of the human fat cell adenylate cyclase

European Journal of Clinical Investigation
H Kather, B Simon

Abstract

In an attempt to characterize the adenylate cyclase-coupled alpha-adrenoceptors of human fat cells the effects of various alpha-adrenergic agonists and antagonists were examined in the presence of 0.05 mmol/l of propranolol. The order of agonist potencies with respect to alpha-adrenergic inhibition was (-)-adrenaline greater than alpha-methyl-(-)-noradrenaline greater than (-)-phenylephrine with half-maximal inhibition occurring at 2 mumol/l of (-)-adrenaline and 7 mumol/l of alpha-methyl-(-)-noradrenaline respectively. The inhibition of adenylate cyclase induced by 0.05 mmol/l of (-)-adrenaline was reversed by the alpha-blocking agents yohimbine and prazosin, with the alpha 2-site-directed antagonist yohimbine being more than 100-times more potent than prazosin which is more active at alpha 1-sites. The results show that the cyclase-coupled alpha-adrenoceptors of human fat cells, which probably represent the physiologically relevant target of antilipolytic catecholamine effects, display characteristic features of the alpha 2-adrenoceptor subtype.

References

Sep 1, 1977·Life Sciences·S Berthelsen, W A Pettinger
Oct 1, 1977·European Journal of Clinical Investigation·H Kather, M Geiger
Jul 1, 1978·European Journal of Pharmacology·D C U'PrichardS H Snyder
Apr 15, 1979·Biochemical Pharmacology·C L WoodR J Lefkowitz
Jan 1, 1975·European Journal of Pharmacology·J WenkeováM Wenke
Jul 1, 1974·Biochemical Pharmacology·S Z Langer
Jan 1, 1974·The Journal of Clinical Investigation·T W BurnsG R Chase
Apr 1, 1974·Analytical Biochemistry·Y SalomonM Rodbell
Jul 1, 1980·Hormone and Metabolic Research = Hormon- Und Stoffwechselforschung = Hormones Et Métabolisme·C BarbieriR Caldara
Mar 21, 1980·European Journal of Pharmacology·M F El-Refai, J H Exton
Oct 1, 1980·European Journal of Clinical Investigation·H KatherB Simon
Jun 1, 1948·The American Journal of Physiology·R P AHLQUIST

❮ Previous
Next ❯

Citations

Jan 1, 1985·European Journal of Clinical Pharmacology·M VelascoO Hernández-Pieretti
Jan 1, 1984·European Journal of Clinical Pharmacology·L A FerraraM Mancini
Nov 15, 1983·Klinische Wochenschrift·H Kather, K Aktories
Jan 1, 1983·Comparative Biochemistry and Physiology. C, Comparative Pharmacology and Toxicology·C CarpeneM Lafontan
Jan 1, 1984·Comparative Biochemistry and Physiology. C, Comparative Pharmacology and Toxicology·H J Mersmann
Jan 1, 1985·Comparative Biochemistry and Physiology. C, Comparative Pharmacology and Toxicology·T B Ng
Feb 1, 1987·European Journal of Clinical Investigation·P ArnerP Blome
Jan 1, 1982·Acta Medica Scandinavica. Supplementum·J E Wikberg
May 1, 1983·Scandinavian Journal of Clinical and Laboratory Investigation·P EngfeldtJ Ostman
Mar 1, 1984·Klinische Wochenschrift·W KroneH Greten
Jan 1, 1982·International Archives of Occupational and Environmental Health·M LehmannJ Keul
Aug 1, 1995·Annals of Medicine·R AantaaM Scheinin
Sep 1, 1981·Molecular and Cellular Endocrinology·J H Exton
May 1, 1989·Metabolism: Clinical and Experimental·L ChristinB V Howard

❮ Previous
Next ❯

Related Concepts

Related Feeds

Adrenergic Receptors: Trafficking

Adrenergic receptor trafficking is an active physiological process where adrenergic receptors are relocated from one region of the cell to another or from one type of cell to another. Discover the latest research on adrenergic receptor trafficking here.